OPRM1 A118G Polymorphisms and Its Role in Opioid Addiction: Implication on Severity and Treatment Approaches

MM Taqi, M Faisal, H Zaman - … and personalized medicine, 2019 - Taylor & Francis
The epidemic of opioid addiction is shaping up as the most serious clinical issues of current
times. Opioids have the greatest propensity to develop addiction after first exposure …

Endogenous opiates and behavior: 2019

RJ Bodnar - Peptides, 2021 - Elsevier
This paper is the forty-second consecutive installment of the annual anthological review of
research concerning the endogenous opioid system, summarizing articles published during …

Genetic susceptibility of opioid receptor genes polymorphism to drug addiction: A candidate-gene association study

LN Al-Eitan, DM Rababa'h, MA Alghamdi - BMC psychiatry, 2021 - Springer
Background Like other complex diseases including drug addiction, genetic factors can
interfere with the disease. In this study, three opioid genes (OPRM1, OPRD1, and OPRK1) …

Genome-wide association study of opioid cessation

JW Cox, RM Sherva, KL Lunetta, EC Johnson… - Journal of Clinical …, 2020 - mdpi.com
The United States is experiencing an epidemic of opioid use disorder (OUD) and overdose-
related deaths. However, the genetic basis for the ability to discontinue opioid use has not …

The pharmacogenetics of opioid treatment for pain management

A Singh, C Zai, AG Mohiuddin… - Journal of …, 2020 - journals.sagepub.com
Background: Opioids are widely used as an analgesic for the treatment of moderate to
severe pain. However, there are interindividual variabilities in opioid response. Current …

Impact of OPRM1 (Mu-opioid Receptor Gene) A112G Polymorphism on Dual Oxycodone and Cocaine Self-administration Behavior in a Mouse Model

Y Zhang, M Randesi, JA Blendy, MJ Kreek… - Neuroscience, 2024 - Elsevier
The use of mu-opioid receptor (MOP-r) agonists such as oxycodone together with cocaine is
prevalent, and deaths attributed to using these combinations have increased. Rationale: It is …

SNP-based and haplotype-based genome-wide association on drug dependence in Han Chinese

H Xu, Y Kang, T Liang, S Lu, X Xia, Z Lu, L Hu, L Guo… - BMC genomics, 2024 - Springer
Background Drug addiction is a serious problem worldwide and is influenced by genetic
factors. The present study aimed to investigate the association between genetics and drug …

Sublingual buprenorphine/naloxone treatment is not affected by OPRM1 A118G and BDNF Va66Met polymorphisms, but alters the plasma beta-endorphin and BDNF …

D Kaya-Akyüzlü, S Özkan-Kotiloğlu, C Bal… - Environmental …, 2022 - Elsevier
The study aimed to examine the genetic contribution to buprenorphine (BUP) treatment in
individuals with opioid use disorder (OUD), with a specific focus on BDNF and OPRM1 …

Endogenous opiates and behavior: 2018

RJ Bodnar - Peptides, 2020 - Elsevier
This paper is the forty-first consecutive installment of the annual anthological review of
research concerning the endogenous opioid system, summarizing articles published during …

Relapse-like behavior in a mouse model of the OPRM1 (mu-opioid receptor) A118G polymorphism: Examination with intravenous oxycodone self-administration

Y Zhang, D Collins, ER Butelman, JA Blendy… - …, 2020 - Elsevier
The widely abused prescription opioid oxycodone is a mu-opioid receptor (MOP-r) agonist
and addiction to such opioids is a relapsing disorder. The human MOP-r gene (OPRM1) has …